Applied BioCode Corporation: Q4 2025 EPS of -NT$1.96
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Applied BioCode Corporation announced its Q4 2025 financial results, reporting an EPS of -NT$1.96, revenue of NT$0.475 billion, and a net loss of NT$0.201 billion, indicating significant R&D investment and potential future growth.
AI Analysis
Frequently Asked Questions
- Q: What is the company code of Applied BioCode Corporation?
- A: The company code of Applied BioCode Corporation is 6598.
- Q: Which industry does Applied BioCode Corporation operate in?
- A: Applied BioCode Corporation operates in the Biotechnology and Healthcare Industry.
- Q: What was the basic earnings per share of Applied BioCode Corporation in Q4 2025?
- A: The basic earnings per share of Applied BioCode Corporation in Q4 2025 was -NT$1.96.
- Q: What was the operating revenue of Applied BioCode Corporation in the fourth quarter of 2025?
- A: The operating revenue of Applied BioCode Corporation in the fourth quarter of 2025 was NT$0.475 billion.
- Q: What was the net profit after tax of Applied BioCode Corporation for 2025 Q4?
- A: The net profit after tax of Applied BioCode Corporation for 2025 Q4 was -NT$0.201 billion.